HKBU to jointly conduct cell therapy research with Golden Meditech following collaboration agreement signing
17 Apr 2019
The Department of Biology at HKBU has signed a collaboration agreement with Golden Meditech Holdings Limited (Golden Meditech). Under the terms of the agreement, the two partners will jointly conduct in-depth research in the area of cell therapy and will focus in particular on the treatment of neurodegenerative diseases using stem cell harvest technology developed at HKBU.
As part of the collaboration, Golden Meditech will contribute a sum of HK$15 million to HKBU in support of a contract research related to cell culture technology and cell therapies that can potentially treat neurodegenerative and other incurable diseases. This five-year in-depth research project will be conducted by a research team led by Professor Ken Yung Kin-lam from the Department of Biology at HKBU.
It is expected that the collaboration between HKBU and Golden Meditech will develop a new therapeutic approach to the treatment of neurodegenerative diseases. The results are expected to benefit patients not only in the Greater China Region but also the world.